TRDA Earnings

Quarterly EPS
$-0.35
Q3 2024
$0.03
Q4 2024
$-0.42
Q1 2025
$-1.04
Q2 2025
$-1.06
Q3 2025
$-0.94
Q4 2025
$-0.95
Q1 2026
$-1.01
Q2 2026
Latest Revenue898.0K
Latest Net Income-42763000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.01898.0K-42763000-53.9%+2.9%
Q1 2026-$0.95875.0K-39717000-95.7%-126.2%
Q4 2025-$0.941.3M-39164000-96.5%-3,233.3%
Q3 2025-$1.061.6M-44134000-91.8%-202.9%
Q2 2025-$1.041.9M-43103000-97.9%-164.6%
Q1 2025-$0.4220.6M-17349000-65.2%-160.0%
Q4 2024$0.0337.4M1.1M-10.6%+110.3%
Q3 2024-$0.3519.6M-14032000-55.3%-132.7%
Q2 2024$1.6194.7M55.0M
Q1 2024$0.7059.1M23.5M
Q4 2023-$0.2941.8M-9544000
Q3 2023$1.0743.7M35.5M
Entrada Therapeutics (TRDA) — Earnings